Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cell therapy trial hopes to tackle tough cancers

NCT ID NCT07341737

Recruiting now Disease control Sponsor: Second Life Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This early-phase trial tests SL-28, a cell therapy made from donor immune cells, in 60 people with advanced solid tumors (like lung, pancreatic, or breast cancer) that haven't responded to standard treatments. The study aims to find a safe dose and see if the therapy can shrink tumors. It is not yet recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SL-28 (donor immune cells given intravenously)
What this could lead to
If it works, this could point toward a new treatment option for people with advanced solid tumors who have run out of standard therapies.
What could go wrong
This is a very early, small trial (60 people) testing safety first. The approach is novel and unproven, so it may not shrink tumors or improve survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenocarcinoma of Lung breast cancer breast neoplasm colorectal cancer colorectal neoplasm endometrial cancer endometrium neoplasm esophageal cancer Esophageal Neoplasms exocrine pancreatic carcinoma gastric cancer gastric neoplasm head and neck cancer Head and Neck Neoplasms intestinal cancer kidney cancer liver cancer Liver Neoplasms lung adenocarcinoma lung cancer lung neoplasm melanoma Neoplasm Metastasis non-small cell lung carcinoma ovarian cancer pancreatic neoplasm prostate cancer renal carcinoma urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER BREAST CANCER COLORECTAL CANCER ENDOMETRIAL CANCER ESOPHAGEAL CANCER HEAD NECK CANCER INTESTINAL CANCER LIVER CANCER LUNG ADENOCARCINOMA LUNG CANCER (NON-SMALL CELL) LUNG CANCER (NSCLC) MELANOMA (SKIN CANCER) OVARIAN CANCER PANCREAS CANCER, METASTATIC PANCREAS CARCINOMA PROSTATE CANCER RENAL CANCER STOMACH (GASTRIC) CANCER

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • The Southern Oncology Clinical Research Unit (SOCRU)

    RECRUITING

    Adelaide, South Australia, 5042, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.